Combination Treatment for Augmenting Language in Children With ASD
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The study will consist of two main elements: the enrollment of 72 children aged 6-11 years
with ASD and low language competency to receive a thrice-weekly one hour language
intervention for 12 weeks; and, beginning at the same time, subjects will be equally
randomized to receive either aripiprazole (Abilify) (flexibly dosed from 2-10 mg per day) or
placebo for 12 weeks.